{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-012521","form_type":"8-K","ticker":"CBUS","cik":"0001705843","company_name":"Cibus, Inc.","filed_at":"2024-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.183635+00:00","generated_at":"2026-06-04T09:58:28.596226+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cibus Q4 net loss $277M on $249M goodwill impairment; cash $32.7M","bullets":["Net loss $277.2M ($12.59/share) vs $2.8M prior year, driven by $249.4M non-cash goodwill and intangible impairment.","Cash $32.7M at Dec 31, 2023; expects to fund operations into early Q3 2024.","R&D expense $14.2M, SG&A $6.8M, both up significantly from prior year due to merger and headcount.","Business progress: PSR in Canola transferred to 10 customers; HT traits in Rice with Bayer, Nutrien, Nuseed, Interoc.","EU Parliament vote supporting new genomic techniques; opened gene editing production facility."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-012521","json":"https://secwatch.observer/filing/0001628280-24-012521.json","markdown":"https://secwatch.observer/filing/0001628280-24-012521.md","text":"https://secwatch.observer/filing/0001628280-24-012521.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1705843/000162828024012521/0001628280-24-012521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1705843/000162828024012521/cbus-20240321.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:58:28.596226+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e6325906d1e43b29d3d544ec1f55beaf95ee3ad8","claim":"Cibus, Inc. reported financial results for the quarter ended December 31, 2023.","evidence_excerpt":"On March 21, 2024, Cibus, Inc. (the “Company”) announced its financial results for the year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1705843/000162828024012521/0001628280-24-012521-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}